Your browser doesn't support javascript.
loading
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study.
Dienstmann, R; Mason, M J; Sinicrope, F A; Phipps, A I; Tejpar, S; Nesbakken, A; Danielsen, S A; Sveen, A; Buchanan, D D; Clendenning, M; Rosty, C; Bot, B; Alberts, S R; Milburn Jessup, J; Lothe, R A; Delorenzi, M; Newcomb, P A; Sargent, D; Guinney, J.
Afiliación
  • Dienstmann R; Computational Oncology, Sage Bionetworks, Seattle, USA.
  • Mason MJ; Oncology Data Science Group, Vall d´Hebron Institute of Oncology and Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Sinicrope FA; Computational Oncology, Sage Bionetworks, Seattle, USA.
  • Phipps AI; Division of Medical Oncology, Mayo Clinic and Mayo Comprehensive Cancer Center, Rochester.
  • Tejpar S; Epidemiology Department, University of Washington and Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
  • Nesbakken A; Molecular Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium.
  • Danielsen SA; Department of Gastrointestinal Surgery, Institute of Clinical Medicine, and K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.
  • Sveen A; Department of Molecular Oncology, Institute for Cancer Research, and K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.
  • Buchanan DD; Department of Molecular Oncology, Institute for Cancer Research, and K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.
  • Clendenning M; Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • Rosty C; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Australia.
  • Bot B; Genetic Medicine and Familial Cancer Centre, The Royal Melbourne Hospital, Parkville, Australia.
  • Alberts SR; Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • Milburn Jessup J; Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • Lothe RA; Envoi Specialist Pathologists, Herston, Queensland, Australia.
  • Delorenzi M; School of Medicine, University of Queensland, Herston, Australia.
  • Newcomb PA; Computational Oncology, Sage Bionetworks, Seattle, USA.
  • Sargent D; Division of Medical Oncology, Mayo Clinic and Mayo Comprehensive Cancer Center, Rochester.
  • Guinney J; Diagnostics Evaluation Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institute of Health, Rockville, USA.
Ann Oncol ; 28(5): 1023-1031, 2017 05 01.
Article en En | MEDLINE | ID: mdl-28453697
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Neoplasias del Colon Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Neoplasias del Colon Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos